top of page

[SEOUL BIO HUB] Open Innovation with Daewon Pharmaceutical

  • Writer: SD&K Holdings
    SD&K Holdings
  • Sep 18, 2024
  • 1 min read

We are pleased to share the news that SD&K is leading the Open Innovation Programme, supported by Seoul Bio Hub, for two bio-startups specialising in DDS (Drug Delivery Systems), in collaboration with Daewon Pharmaceutical.


As part of our exciting journey, we held an opening ceremony with Seoul Metropolitan City and KIST.


Media:


 
 
 

Comments

bottom of page